Global Alzheimer’s Disease Diagnostic Market Size, Status and Forecast 2024-2031

Report ID: 920330 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Nervous System Examination
        1.2.3 Genetic Testing
        1.2.4 Minor Mental State Examination (Mmse)
        1.2.5 Brain Imaging
    1.3 Market by Application
        1.3.1 Global Alzheimer’s Disease Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Early-Onset Alzheimer's Disease
        1.3.3 Familial Alzheimer's Disease
        1.3.4 Late-Onset Alzheimer's Disease
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Alzheimer’s Disease Diagnostic Market Perspective (2016-2027)
    2.2 Alzheimer’s Disease Diagnostic Growth Trends by Regions
        2.2.1 Alzheimer’s Disease Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Alzheimer’s Disease Diagnostic Historic Market Share by Regions (2016-2021)
        2.2.3 Alzheimer’s Disease Diagnostic Forecasted Market Size by Regions (2022-2027)
    2.3 Alzheimer’s Disease Diagnostic Industry Dynamic
        2.3.1 Alzheimer’s Disease Diagnostic Market Trends
        2.3.2 Alzheimer’s Disease Diagnostic Market Drivers
        2.3.3 Alzheimer’s Disease Diagnostic Market Challenges
        2.3.4 Alzheimer’s Disease Diagnostic Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue
        3.1.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue (2016-2021)
        3.1.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Players (2016-2021)
    3.2 Global Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Alzheimer’s Disease Diagnostic Revenue
    3.4 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio
        3.4.1 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Diagnostic Revenue in 2020
    3.5 Alzheimer’s Disease Diagnostic Key Players Head office and Area Served
    3.6 Key Players Alzheimer’s Disease Diagnostic Product Solution and Service
    3.7 Date of Enter into Alzheimer’s Disease Diagnostic Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer’s Disease Diagnostic Breakdown Data by Type
    4.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Type (2016-2021)
    4.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2022-2027)

5 Alzheimer’s Disease Diagnostic Breakdown Data by Application
    5.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Application (2016-2021)
    5.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Alzheimer’s Disease Diagnostic Market Size (2016-2027)
    6.2 North America Alzheimer’s Disease Diagnostic Market Size by Type
        6.2.1 North America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
        6.2.2 North America Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
        6.2.3 North America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
    6.3 North America Alzheimer’s Disease Diagnostic Market Size by Application
        6.3.1 North America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
        6.3.2 North America Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
        6.3.3 North America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
    6.4 North America Alzheimer’s Disease Diagnostic Market Size by Country
        6.4.1 North America Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021)
        6.4.2 North America Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Alzheimer’s Disease Diagnostic Market Size (2016-2027)
    7.2 Europe Alzheimer’s Disease Diagnostic Market Size by Type
        7.2.1 Europe Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
        7.2.2 Europe Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
        7.2.3 Europe Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
    7.3 Europe Alzheimer’s Disease Diagnostic Market Size by Application
        7.3.1 Europe Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
        7.3.2 Europe Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
        7.3.3 Europe Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
    7.4 Europe Alzheimer’s Disease Diagnostic Market Size by Country
        7.4.1 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021)
        7.4.2 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size (2016-2027)
    8.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type
        8.2.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
    8.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application
        8.3.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
    8.4 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region
        8.4.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Alzheimer’s Disease Diagnostic Market Size (2016-2027)
    9.2 Latin America Alzheimer’s Disease Diagnostic Market Size by Type
        9.2.1 Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
        9.2.2 Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
        9.2.3 Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
    9.3 Latin America Alzheimer’s Disease Diagnostic Market Size by Application
        9.3.1 Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
        9.3.2 Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
        9.3.3 Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
    9.4 Latin America Alzheimer’s Disease Diagnostic Market Size by Country
        9.4.1 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021)
        9.4.2 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size (2016-2027)
    10.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type
        10.2.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
    10.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application
        10.3.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
    10.4 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country
        10.4.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Eli Lilly and Company
        11.1.1 Eli Lilly and Company Company Details
        11.1.2 Eli Lilly and Company Business Overview
        11.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Introduction
        11.1.4 Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.1.5 Eli Lilly and Company Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Alzheimer’s Disease Diagnostic Introduction
        11.2.4 Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck Alzheimer’s Disease Diagnostic Introduction
        11.3.4 Merck Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.3.5 Merck Recent Development
    11.4 F. Hoffmann-La Roche
        11.4.1 F. Hoffmann-La Roche Company Details
        11.4.2 F. Hoffmann-La Roche Business Overview
        11.4.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Introduction
        11.4.4 F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.4.5 F. Hoffmann-La Roche Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Alzheimer’s Disease Diagnostic Introduction
        11.5.4 Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.5.5 Pfizer Recent Development
    11.6 TauRx
        11.6.1 TauRx Company Details
        11.6.2 TauRx Business Overview
        11.6.3 TauRx Alzheimer’s Disease Diagnostic Introduction
        11.6.4 TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.6.5 TauRx Recent Development
    11.7 Alector
        11.7.1 Alector Company Details
        11.7.2 Alector Business Overview
        11.7.3 Alector Alzheimer’s Disease Diagnostic Introduction
        11.7.4 Alector Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.7.5 Alector Recent Development
    11.8 Accera
        11.8.1 Accera Company Details
        11.8.2 Accera Business Overview
        11.8.3 Accera Alzheimer’s Disease Diagnostic Introduction
        11.8.4 Accera Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.8.5 Accera Recent Development
    11.9 Treventis Corporation
        11.9.1 Treventis Corporation Company Details
        11.9.2 Treventis Corporation Business Overview
        11.9.3 Treventis Corporation Alzheimer’s Disease Diagnostic Introduction
        11.9.4 Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.9.5 Treventis Corporation Recent Development
    11.10 Neuro-Bio
        11.10.1 Neuro-Bio Company Details
        11.10.2 Neuro-Bio Business Overview
        11.10.3 Neuro-Bio Alzheimer’s Disease Diagnostic Introduction
        11.10.4 Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.10.5 Neuro-Bio Recent Development
    11.11 Cognition Therapeutics
        11.11.1 Cognition Therapeutics Company Details
        11.11.2 Cognition Therapeutics Business Overview
        11.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Introduction
        11.11.4 Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
        11.11.5 Cognition Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Nervous System Examination
    Table 3. Key Players of Genetic Testing
    Table 4. Key Players of Minor Mental State Examination (Mmse)
    Table 5. Key Players of Brain Imaging
    Table 6. Global Alzheimer’s Disease Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Alzheimer’s Disease Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Alzheimer’s Disease Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Alzheimer’s Disease Diagnostic Market Share by Regions (2016-2021)
    Table 10. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Alzheimer’s Disease Diagnostic Market Share by Regions (2022-2027)
    Table 12. Alzheimer’s Disease Diagnostic Market Trends
    Table 13. Alzheimer’s Disease Diagnostic Market Drivers
    Table 14. Alzheimer’s Disease Diagnostic Market Challenges
    Table 15. Alzheimer’s Disease Diagnostic Market Restraints
    Table 16. Global Alzheimer’s Disease Diagnostic Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Alzheimer’s Disease Diagnostic Market Share by Players (2016-2021)
    Table 18. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2020)
    Table 19. Ranking of Global Top Alzheimer’s Disease Diagnostic Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Alzheimer’s Disease Diagnostic Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Alzheimer’s Disease Diagnostic Product Solution and Service
    Table 23. Date of Enter into Alzheimer’s Disease Diagnostic Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2016-2021)
    Table 27. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Alzheimer’s Disease Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2016-2021)
    Table 31. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Eli Lilly and Company Company Details
    Table 64. Eli Lilly and Company Business Overview
    Table 65. Eli Lilly and Company Alzheimer’s Disease Diagnostic Product
    Table 66. Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 67. Eli Lilly and Company Recent Development
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Alzheimer’s Disease Diagnostic Product
    Table 71. Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 72. Novartis Recent Development
    Table 73. Merck Company Details
    Table 74. Merck Business Overview
    Table 75. Merck Alzheimer’s Disease Diagnostic Product
    Table 76. Merck Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 77. Merck Recent Development
    Table 78. F. Hoffmann-La Roche Company Details
    Table 79. F. Hoffmann-La Roche Business Overview
    Table 80. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product
    Table 81. F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 82. F. Hoffmann-La Roche Recent Development
    Table 83. Pfizer Company Details
    Table 84. Pfizer Business Overview
    Table 85. Pfizer Alzheimer’s Disease Diagnostic Product
    Table 86. Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 87. Pfizer Recent Development
    Table 88. TauRx Company Details
    Table 89. TauRx Business Overview
    Table 90. TauRx Alzheimer’s Disease Diagnostic Product
    Table 91. TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 92. TauRx Recent Development
    Table 93. Alector Company Details
    Table 94. Alector Business Overview
    Table 95. Alector Alzheimer’s Disease Diagnostic Product
    Table 96. Alector Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 97. Alector Recent Development
    Table 98. Accera Company Details
    Table 99. Accera Business Overview
    Table 100. Accera Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 101. Accera Recent Development
    Table 102. Treventis Corporation Company Details
    Table 103. Treventis Corporation Business Overview
    Table 104. Treventis Corporation Alzheimer’s Disease Diagnostic Product
    Table 105. Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 106. Treventis Corporation Recent Development
    Table 107. Neuro-Bio Company Details
    Table 108. Neuro-Bio Business Overview
    Table 109. Neuro-Bio Alzheimer’s Disease Diagnostic Product
    Table 110. Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 111. Neuro-Bio Recent Development
    Table 112. Cognition Therapeutics Company Details
    Table 113. Cognition Therapeutics Business Overview
    Table 114. Cognition Therapeutics Alzheimer’s Disease Diagnostic Product
    Table 115. Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
    Table 116. Cognition Therapeutics Recent Development
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Alzheimer’s Disease Diagnostic Market Share by Type: 2020 VS 2027
    Figure 2. Nervous System Examination Features
    Figure 3. Genetic Testing Features
    Figure 4. Minor Mental State Examination (Mmse) Features
    Figure 5. Brain Imaging Features
    Figure 6. Global Alzheimer’s Disease Diagnostic Market Share by Application: 2020 VS 2027
    Figure 7. Early-Onset Alzheimer's Disease Case Studies
    Figure 8. Familial Alzheimer's Disease Case Studies
    Figure 9. Late-Onset Alzheimer's Disease Case Studies
    Figure 10. Alzheimer’s Disease Diagnostic Report Years Considered
    Figure 11. Global Alzheimer’s Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Alzheimer’s Disease Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Alzheimer’s Disease Diagnostic Market Share by Regions: 2020 VS 2027
    Figure 14. Global Alzheimer’s Disease Diagnostic Market Share by Regions (2022-2027)
    Figure 15. Global Alzheimer’s Disease Diagnostic Market Share by Players in 2020
    Figure 16. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Alzheimer’s Disease Diagnostic Revenue in 2020
    Figure 18. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2016-2021)
    Figure 19. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2022-2027)
    Figure 20. North America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
    Figure 22. North America Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
    Figure 23. North America Alzheimer’s Disease Diagnostic Market Share by Country (2016-2027)
    Figure 24. United States Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
    Figure 28. Europe Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
    Figure 29. Europe Alzheimer’s Disease Diagnostic Market Share by Country (2016-2027)
    Figure 30. Germany Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Alzheimer’s Disease Diagnostic Market Share by Region (2016-2027)
    Figure 40. China Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
    Figure 48. Latin America Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
    Figure 49. Latin America Alzheimer’s Disease Diagnostic Market Share by Country (2016-2027)
    Figure 50. Mexico Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Alzheimer’s Disease Diagnostic Market Share by Country (2016-2027)
    Figure 56. Turkey Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Eli Lilly and Company Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 60. Novartis Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 61. Merck Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 63. Pfizer Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 64. TauRx Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 65. Alector Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 66. Accera Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 67. Treventis Corporation Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 68. Neuro-Bio Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 69. Cognition Therapeutics Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly and Company
Novartis
Merck
F. Hoffmann-La Roche
Pfizer
TauRx
Alector
Accera
Treventis Corporation
Neuro-Bio
Cognition Therapeutics
Frequently Asked Questions
Alzheimer’s Disease Diagnostic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alzheimer’s Disease Diagnostic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alzheimer’s Disease Diagnostic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports